GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bactiguard Holding AB (LTS:0QV2) » Definitions » ROE % Adjusted to Book Value

Bactiguard Holding AB (LTS:0QV2) ROE % Adjusted to Book Value : -1.51% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bactiguard Holding AB ROE % Adjusted to Book Value?

Bactiguard Holding AB's ROE % for the quarter that ended in Mar. 2024 was -11.37%. Bactiguard Holding AB's PB Ratio for the quarter that ended in Mar. 2024 was 7.55. Bactiguard Holding AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -1.51%.


Bactiguard Holding AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Bactiguard Holding AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bactiguard Holding AB ROE % Adjusted to Book Value Chart

Bactiguard Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 -0.82 -1.20 -1.26 -5.30

Bactiguard Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.87 -10.39 -4.02 -4.80 -1.51

Competitive Comparison of Bactiguard Holding AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Bactiguard Holding AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bactiguard Holding AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bactiguard Holding AB's ROE % Adjusted to Book Value falls into.



Bactiguard Holding AB ROE % Adjusted to Book Value Calculation

Bactiguard Holding AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-32.60% / 6.15
=-5.30%

Bactiguard Holding AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-11.37% / 7.55
=-1.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bactiguard Holding AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bactiguard Holding AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bactiguard Holding AB (LTS:0QV2) Business Description

Traded in Other Exchanges
Address
Alfred Nobels Alle 150, Box 15, Tullinge, SWE, SE 146 21
Bactiguard Holding AB is a Sweden-based medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Bactiguard Holding AB (LTS:0QV2) Headlines

No Headlines